Archive
Azenta Announces $500 Million Accelerated Share Repurchase Agreement
Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into an accelerated share repurchase agreement ("ASR") with JP Morgan Chase Bank, N.A. (the "Dealer") to repurchase $500 million of...
Azenta to participate in the 5th Annual Evercore ISI HealthCONx Conference
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the virtual 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, which includes a...
Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program
Delivered on Expected Q4'22 Revenue of $138 million Strong Double-Digit Organic Growth Excluding COVID for Q4 and Full Fiscal Year Plan to Repurchase at Least $1 Billion of Common Stock Over the...
Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors
Azenta, Inc. (Nasdaq: AZTA) today announced that Tina S. Nova, Ph.D. and Dorothy E. Puhy have been nominated for election to its Board of Directors at the Company's 2023 Annual General Meeting....
Azenta to participate in the Stephens Annual Investment Conference
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Stephens Annual Investment Conference in Nashville, Tennessee, on Wednesday, November 16, 2022, which...
Azenta and the Government of Luxembourg Announce a Memorandum of Understanding to Facilitate Continued Healthcare Technology Development in Luxembourg
Azenta, Inc. (Nasdaq: AZTA) and the Government of Luxembourg today announced the signing of a Memorandum of Understanding ("MoU") to facilitate continued healthcare technology development in...
Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast
Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will...
Azenta Hosts First Cryogenic Considerations for Cell & Gene Therapy Symposium
Symposium brings together over 100 participants across 60+ organizations. CHELMSFORD, Mass., Oct. 25, 2022 /PRNewswire/ --Azenta Life Sciences, a leading provider of life sciences solutions...
Azenta Announces Completion of B Medical Systems Acquisition
Azenta, Inc. (Nasdaq: AZTA) today announced that it has closed its previously announced acquisition of B Medical Systems S.รก r.l and its subsidiaries ("B Medical"), a market leader in...
Azenta to Participate in the Baird 2022 Global Healthcare Conference
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2022 Global Healthcare Conference in New York City, on Wednesday, September 14, 2022, which...